Bates SE - Search Results

1

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.

Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, Zain J, Prince HM, Leonard JP, Geskin LJ, Reeder C, Joske D, Figg WD, Gardner ER, Steinberg SM, Jaffe ES, Stetler-Stevenson M, Lade S, Fojo AT, Bates SE. Piekarz RL, et al. Among authors: bates se. J Clin Oncol. 2009 Nov 10;27(32):5410-7. doi: 10.1200/JCO.2008.21.6150. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826128 Free PMC article. Clinical Trial.

2

Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.

Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT. Herzog CE, et al. Among authors: bates se. J Natl Cancer Inst. 1992 May 6;84(9):711-6. doi: 10.1093/jnci/84.9.711. J Natl Cancer Inst. 1992. PMID: 1349044

3

Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate.

Bates SE, Currier SJ, Alvarez M, Fojo AT. Bates SE, et al. Biochemistry. 1992 Jul 21;31(28):6366-72. doi: 10.1021/bi00143a002. Biochemistry. 1992. PMID: 1352990

4

Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.

Bates SE, Shieh CY, Mickley LA, Dichek HL, Gazdar A, Loriaux DL, Fojo AT. Bates SE, et al. J Clin Endocrinol Metab. 1991 Jul;73(1):18-29. doi: 10.1210/jcem-73-1-18. J Clin Endocrinol Metab. 1991. PMID: 1675220

5

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.

Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):688-95. doi: 10.1002/ijc.2910490511. Int J Cancer. 1991. PMID: 1682279

6

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512. Int J Cancer. 1991. PMID: 1682280

7

Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.

Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE. Murphy LD, et al. Among authors: bates se. Biochemistry. 1990 Nov 13;29(45):10351-6. doi: 10.1021/bi00497a009. Biochemistry. 1990. PMID: 1979752

8

Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.

Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N, Fojo AT. Mickley LA, et al. Among authors: bates se. J Biol Chem. 1989 Oct 25;264(30):18031-40. J Biol Chem. 1989. PMID: 2572588 Free article.

9

Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.

Bates SE, Mickley LA, Chen YN, Richert N, Rudick J, Biedler JL, Fojo AT. Bates SE, et al. Mol Cell Biol. 1989 Oct;9(10):4337-44. doi: 10.1128/mcb.9.10.4337-4344.1989. Mol Cell Biol. 1989. PMID: 2573830 Free PMC article.

10

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters